home / stock / dtcff / dtcff news

DTCFF News and Press, Defence Therapeutics Inc Cl A From 11/14/23

Stock Information
Company Name: Defence Therapeutics Inc Cl A
Stock Symbol: DTCFF
Market: OTC
Website: defencetherapeutics.com
Menu
DTCFF DTCFF Quote DTCFF Short DTCFF News DTCFF Articles DTCFF Message Board
Get DTCFF Alerts

News, Short Squeeze, Breakout and More Instantly...
DTCFF - Defence's Successful Submission of an Investigational New Drug (IND) Application for AccuTOX(R) as an Injectable Anticancer Treatment for Solid Tumors

Vancouver, British Columbia--(Newsfile Corp. - November 14, 2023) - Defence Therapeutics Inc. (CSE: DTC) (OTC Pink: DTCFF) (FSE: DTC) (" Defence " or the " Company "), one of the leading Canadian biotechnology companies working in the field of immune-oncology is pleased to announce that it has su...
DTCFF - Defence Therapeutics Key Platform Patent Accepted Broadly Covering Vaccine Technology

Vancouver, British Columbia--(Newsfile Corp. - November 7, 2023) -  Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing cutting-edge vaccines, therapeutics, and drug delivery technologies aga...

DTCFF - Global Cancer Vaccines Market Share Is Expected To Reach $19.27 Billion By 2030

2023-10-25 08:30:32 ET Palm Beach, FL – October 25, 2023 – FinancialNewsMedia.com News Commentary – The R&D for cancer vaccines has been growing in the last few years and is projected to continue through the next decade. A cancer vaccine is used to eithe...

DTCFF - Defence's AccuTOX(R) And Antigen Cross-Presentation: Discovery Leads Towards the Development of a Groundbreaking Platform

Vancouver, British Columbia--(Newsfile Corp. - October 25, 2023) -  Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a leading Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delive...
DTCFF - Defence's Novel Accutox(TM) Continues to Surprise on Results Against Cancer

Vancouver, British Columbia--(Newsfile Corp. - October 18, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is...

DTCFF - Defence's Delivery of Encapsulated AccuTOX(TM)-Chitosan Nanoparticles Triggers Complete Tumor Regression in Animals with Pre-Established Solid Lymphoma

Vancouver, British Columbia--(Newsfile Corp. - October 17, 2023) - Defence Therapeutics Inc. (CSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce that sys...

DTCFF - Defence Announces Peer-reviewed Publication of Its Preclinical Data on Accum(R) as an Anti-Cancer Molecule in the Journal of Cancer Science

Vancouver, British Columbia--(Newsfile Corp. - October 10, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company developing various products for the immune-oncology vaccines and drug delivery technologies, is pleased to...
DTCFF - Defence to Present Three of Its Leading Products at the Upcoming Festival of Biologics in Basel, Switzerland

Vancouver, British Columbia--(Newsfile Corp. - October 6, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is ...

DTCFF - Defence's Accum(R)-mRNA Lipid Nanoparticles Elicit Antibody Response 2X Stronger than Standard mRNA Vaccines

Vancouver, British Columbia--(Newsfile Corp. - September 25, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, ...

DTCFF - Defence to Collaborate with Native Ads for Marketing Campaign

Vancouver, British Columbia--(Newsfile Corp. - September 22, 2023) - Defence Therapeutics Inc.  (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technolo...
Previous 10 Next 10